Overview

Regenerative medicine has evolved significantly and today includes several commercialized stem cell therapies. Researchers have made notable technological developments in stem cell therapies to overcome challenges related to large-scale manufacturing and cell quality.

Stem cell research is more focused on induced pluripotent stem cells than on mesenchymal and hematopoietic stem cells, a transition caused by the fast-paced developments in induced pluripotent stem cells (iPSC) research. Developments in technology platforms help improve overall stem cell therapy and selection and reduce overall costs. Emerging companies are establishing newer cell isolation, characterization, and screening processes to ensure constant cell viability and maintenance.

• How can advancements in iPSC research transform the landscape of stem cell therapies?
• Which companies are adopting new technology platforms to scale stem cell therapy R&D?
• How can artificial intelligence and machine learning enhance stem cell imaging and real-time tracking in research and clinical applications?

Quick links

Click here to download the sample of this analysis

Already a member? Click here to access the analysis

Frost Honorarium Program

Unlock a $1,000 Incentive with a Complimentary Growth Dialog

Engage with our industry experts for a discussion to explore new growth opportunities for your business.

As a token of appreciation, you will receive a $1,000 honorarium—redeemable towards any of our products or services.

Schedule Your Growth Dialog Today!